tadalafil has been researched along with tubacin in 1 studies
| Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (tubacin) | Trials (tubacin) | Recent Studies (post-2010) (tubacin) |
|---|---|---|---|---|---|
| 1,742 | 392 | 1,089 | 102 | 0 | 75 |
| Protein | Taxonomy | tadalafil (IC50) | tubacin (IC50) |
|---|---|---|---|
| Histone deacetylase 3 | Homo sapiens (human) | 1.19 | |
| Aspartyl/asparaginyl beta-hydroxylase | Homo sapiens (human) | 4.5725 | |
| Histone deacetylase 1 | Homo sapiens (human) | 1.245 | |
| Histone deacetylase 7 | Homo sapiens (human) | 9.7 | |
| Histone deacetylase 2 | Homo sapiens (human) | 5.5187 | |
| HD2 type histone deacetylase HDA106 | Zea mays | 2 | |
| Polyamine deacetylase HDAC10 | Homo sapiens (human) | 3.71 | |
| Histone deacetylase 11 | Homo sapiens (human) | 3.79 | |
| Histone deacetylase 8 | Homo sapiens (human) | 1.8029 | |
| Histone deacetylase 6 | Homo sapiens (human) | 0.4668 | |
| Histone deacetylase 9 | Homo sapiens (human) | 4.31 | |
| Histone deacetylase 5 | Homo sapiens (human) | 3.35 | |
| Nuclear receptor corepressor 2 | Homo sapiens (human) | 1.27 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuadrado-Tejedor, M; de Miguel, I; Espelosin, M; Estella-Hermoso de Mendoza, A; García-Barroso, C; Garcia-Osta, A; Haizhong, T; Musheng, X; Oyarzabal, J; Pérez-González, M; Rabal, O; Sáez, E; Sánchez-Arias, JA; Ugarte, A; Ursua, S; Wei, W | 1 |
1 other study(ies) available for tadalafil and tubacin
| Article | Year |
|---|---|
Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Cell Line; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Drug Design; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Humans; Molecular Structure; Neuroglia; Phosphodiesterase 5 Inhibitors; Structure-Activity Relationship | 2018 |